Items where Subject is "Pharmaceutical industry"

B

Bertini, M and Tavassoli, N T (2015) Case study: Can one business unit have 2 revenue models? Harvard Business Review, 93 (3). pp. 121-123. ISSN 0017-8012

Birkinshaw, J, Visnjic, I and Best, S (2018) Responding to a potentially disruptive technology: how big pharma embraced biotechnology. California Management Review, 60 (4). pp. 74-100. ISSN 0008-1256

G

Gallien, J, Rashkova, I, Atun, R and Yadav, P (2016) National drug stockout risks and the global fund disbursement process for procurement. Production and Operations Management, 26 (6). pp. 997-1014. ISSN 1059-1478

Gao, H, Pauphilet, J, Struble, T, Coley, C and Jensen, K F (2021) Direct optimization across computer generated reaction networks balances materials use and feasibility of synthesis plans for molecule libraries. Journal of Chemical Information and Modeling, 61 (1). pp. 493-504. ISSN 1549-9596

M

Morgan, S G, Cunningham, C and Law, M R (2012) Drug development: innovation or imitation deficit? British Medical Journal, 345 (e5880). ISSN 0959-8138

Morgan, S and Cunningham, C (2008) The effect of evidence-based drug coverage policies on pharmaceutical R&D: a case study from British Columbia. Healthcare Policy, 3 (3). e128-e153. ISSN 1715-6572

Morgan, S, Grootendorst, P, Lexchin, J and Cunningham, C (2011) The cost of drug development: a systematic review. Health Policy, 100 (1). pp. 4-17. ISSN 0168-8510

S

Sivanathan, N and Hakkar, H (2017) The unintended consequences of argument dilution in direct-to-consumer drug advertisments. Nature Human Behaviour, 1 (11). pp. 797-802. ISSN 2397-3374

Sivanathan, N and Kakkar, H (2019) How Drug Company Ads Downplay Risks. Scientific American. ISSN 0036-8733

Stern, Philip (1994) Patterns of pharmaceutical prescribing. Doctoral thesis, University of London: London Business School.